Premium
A Carlyle Group-backed pharmaceuticals platform has agreed to acquire a bulk drugs business, the second active pharmaceuticals...
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.